Boston Scientific (BSX) PT Raised to $117 at Canaccord Genuity
Tweet Send to a Friend
(Updated - February 6, 2025 6:25 AM EST)
Canaccord Genuity analyst William Plovanic raised the price target on Boston ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst William Plovanic raised the price target on Boston ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
